Acne is a chronic inflammatory disease of the pilosebaceous unit. Its pathophysiology includes hyperseborrhoea, abnormal follicular keratinization and Propionibacterium acnes proliferation in the pilosebaceous unit. Recent research has shed some new light on the involvement of the sebaceous gland, as well as on the pro-inflammatory activity of the cutaneous microbiome. During puberty, alteration of the sebaceous lipid profile, called dysseborrhoea, stress, irritation, cosmetics and potential dietary factors lead to inflammation and formation of different types of acne lesions. Dysbiosis, the process leading to a disturbed skin barrier and disequilibrium of the cutaneous microbiome, resulting in the proliferation of P. acnes strains, is another important process that triggers acne. P. acnes activates the innate immunity via the expression of protease activated receptors (PARs), tumour necrosis factor (TNF) a and toll-like receptors (TLRs), and the production of interferon (INF) c, interleukins (IL-8, IL12, IL-1), TNF, and matrix metalloproteinases (MMPs) by keratinocytes, resulting in the hyperkeratinization of the pilosebaceous unit. Rebalancing the natural microbiome of the skin by restoring the natural skin barrier, limiting the proliferation of P. acnes on the skin by using topical antibacterials which do not cause resistance and regulating quantity and quality of sebum will be the main acne treatment challenges in the future. The aim of this article to provide an update on the involvement of the sebaceous gland, the innate immunity and the cutaneous microbiome, how all of these factors promote acne and to illustrate their links with current and future treatments.
Introduction
Acne is a chronic inflammatory disease of the pilosebaceous unit. 1 It commonly occurs at puberty but is also observed in adults. 2 Its pathophysiology involves three actors, hyperseborrhoea, abnormal follicular keratinization and Propionibacterium acnes proliferation in the pilosebaceous unit. As a result of their interaction, the cutaneous microenvironment changes and leads to inflammatory reactions of the host that foster acne lesion progression. 2, 3 Recent research has put some new light on the involvement of the sebaceous gland, as well as on the proinflammatory activity of the cutaneous microbiome in the pathophysiology of acne. The objective of this article was to provide an update regarding the involvement of the sebaceous gland, the innate immunity and the cutaneous microbiome in acne. The second objective was to open a new perspective of treatment options.
Methods
The author conducted a literature review of the most recent data about the pathophysiology of acne.
The sebaceous gland
Sebum production is induced by different receptors expressed by the sebaceous gland. In addition to the well-described histamine receptor activated by histamines, the hormonal DHT receptor, activated by androgens, and the neuromodulator receptor, mainly substance P and corticotrophin-releasing hormone (CRH) receptor which are mainly activated by stress, recent molecular research has identified three other receptors that are expressed by the sebocyte and that control sebum production (Fig. 1 ). [4] [5] [6] Each of these newly identified receptors is activated by a dietary substance. The peroxisome proliferator-activated receptors (PPARa, b and c) are stimulated by free fatty acids and cholesterol, the insulin-like growth factor (IGF)-1 receptor by sugar and leptin receptor by fat. [7] [8] [9] Leptin is a hormone secreted by adipocytes that regulates bodyweight and is also known to link lipid metabolism with inflammation in various cell types. In the sebocyte, it is responsible for creating lipid droplets within the cell and has recently been shown to induce pro-inflammatory enzyme and cytokine (interleukin (IL)-6 and IL-8) secretion as well. 9 This result suggests that leptin is a novel player in inducing inflammation and altering lipid profile in sebocytes and could be a link between diet and development of inflammatory acne. The link between acne and diet is further supported by a recent case-control study of predictive factors for acne. 10 Apart from the well-known relationship between family history and acne, the investigators found that a high body mass index (BMI) was also a predictive factor for an increased risk of developing moderate to severe acne in adolescents and young adults. Furthermore, a population-based study of acne and BMI in adolescents reported that overweight as well as obesity may be potentially associated with acne in girls aged 18 and 19 years, 11 even though proofs are still lacking.
Peripheral hyperandrogenia
Women suffering from hyperandrogenia usually present with premenstrual flare, a mild increase in serum DHEA levels and an increased antimullerian serum hormone level but with otherwise normal blood hormone levels and vellus hair on the upper lip, the peri-ocular and malar area. 12, 13 Interestingly, further evidence for peripheral hyperandrogenia was recently demonstrated following the new regulations for oral contraceptive prescription put in place in France in 2013. 14 Following an increase in cerebral stroke in young women taking the third-generation pill, the French Health Agency recommended in 2012 that gynaecologists, dermatologists and general practitioners switch their patients back to second-generation contraceptives. This widespread change in contraceptive prescription from late-generation contraception to early-generation contraception turned out to be significant for dermatologists. The French survey conducted a year after the new regulations came into effect showed that the switch to a second-generation contraceptive worsened acne in 83.9% of study participants. This thus confirmed the link between peripheral hyperandrogenia and abnormal androgen receptor activation. The observations supported the investigation of the potential value of spironolactone as an alternative to isotretinoin to improve acne symptoms in this patient group. Although spironolactone is not indicated for acne by either the EMEA or FDA, there is rationale regarding its use in the condition: spironolactone interferes with the hormone-controlled sebum and sweat gland secretion, and with androgen-stimulated hair growth. 15 Based on this, a pilot study was performed in 16 patients who received 75 mg to 150 mg/day oral spironolactone and a third-generation pill and topical BPO 0.25% or a topical retinoid daily with very positive results at 6 and 12 months, confirming the clinical benefit of oral spironolactone in adult women with acne. 16 Since that time, the off-label use of spironolactone in this subgroup of patients has been tested further. 17, 18 Very recently, the topical delivery of spironolactone has been shown to be superior with solid lipid nanoparticles that deliver the drug into the dermis. 19 However, further testing is required to confirm this clinically.
The endocannabinoid system
Endocannabinoids represent a class of endogenous lipid mediators that are involved in various biological processes, both centrally and peripherally. 20 Recent studies have intriguingly suggested the existence of a functional endocannabinoid system (ECS) in the skin and implicated it in various biological processes (e.g. proliferation, growth, differentiation, apoptosis and cytokine, mediator or hormone production of various cell types of the skin and appendages, such as the hair follicle and sebaceous gland). It seems that the main physiological function of the cutaneous ECS is to constitutively control the proper and well-balanced proliferation, differentiation and survival, as well as immune competence and/or tolerance, of skin cells. The disruption of this delicate balance might facilitate the development of multiple pathological conditions and diseases of the skin. 21, 22 Recently, the ECS has attracted some interest in the treatment of acne by controlling sebum secretion. 23 An in vitro study performed in 2014 found that cannabidiol has lipostatic, antiproliferative and anti-inflammatory effects which could make this non-psychotrophic cannabinoid agent a promising therapy for acne vulgaris.
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The cutaneous microbiome
The skin microbiome is the collective genome of the resident microbial inhabitants (viruses, bacteria, fungi and parasites), also called the microbiota, present on the skin and its appendages. It is a unique microbial fingerprint. 25, 26 It controls the balance of the microbiota and of the transient microbial colonization and assists the host's innate immunity. It is constantly changing, being potentially influenced by external (mechanic factors, comedogenic cosmetics, aggressive detergents, drugs, diet) and internal factors (hormonal or genetic factors).
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Even though commensal, some inhabitants have been connected with inflammatory diseases of the skin, such as P. acnes (acne), Malassezia furfur (seborrhoeic dermatitis) and demodex (rosacea). Other transient microbes, such as Staphylococcus aureus and Streptococcus pyogenes, are known pathogens. [30] [31] [32] [33] In a balanced skin microbiome, Staphylococcus epidermidis limits overcolonization and the inflammatory response of the skin by the different P. acnes strains identified through the release of succinic acid, a fatty acid fermentation product, and suppresses P. acnes-induced IL-6 and TNF-a production by keratinocytes. [34] [35] [36] [37] [38] Conversely, P. acnes limits the proliferation of S. aureus and S. pyogenes in maintaining an acidic pH of the pilosebaceous follicle by hydrolysing sebum triglycerides and by secreting propionic acid. 33, 39 Therefore, any modification of the natural microbiome composition may lead to a disturbed skin barrier, an effect which is also called dysbiosis, and which triggers the activation of the innate immunity leading to inflammation. 40 In acne, dysbiosis may be paralleled by a qualitative and quantitative change of the sebum, called dysseborrhoea and in a modified profile of P. acnes, with all six different phylotypes differing between patients with and without acne. 41, 42 As a result, inflammation worsens.
As such, it has been shown that TLR-2 expression increases with the severity of the disease and that cytokines are produced as a result of the interaction between P. acnes and TLR-2, defensins and MMP via PAR-2R activation. 43, 44 This worsening via the stimulation of TLR-2, IL-8 and MMP-9, which is diffused from the pilosebaceous gland to the dermis and epidermis, was five times more pro-inflammatory than S. aureus or Streptococcus pyogenes.
43,45-49
Rebalancing the natural equilibrium of the microbiome, allowing the restoration of the natural skin barrier, is, therefore, one of the main aims in the treatment of acne today.
The innate immunity and P. acnes
Within the skin, both innate and adaptive mechanisms contribute to the host immune function. [50] [51] [52] Keratinocytes play an important role in the immune response of the skin. They express a number of pattern recognition receptors (PRRs) including Toll-like receptors (TLRs) and protease-activated receptors (PARs) that recognize microbes through the recognition of different conserved molecular entities. While expressing a number of antimicrobial peptides (AMPs, such as dermcidin), cytokines (INF-c, IL-8, IL-12, TNF, IL-1, MMPs) and chemokines at steady state, activation of PRRs can rapidly increase the expression of these molecules, resulting in direct antimicrobial effects as well as recruitment and education of additional immune cells. [53] [54] [55] In the process of inflammation triggered by P. acnes, secretion of IL-1b by monocytes and by sebocytes through activation of the key inflammasome gene NLRP3 has been observed. This mechanism is regulated by proteases and reactive oxygen species (ROS). [56] [57] [58] Moreover, P. acnes promotes mixed Th17/Th1 responses by inducing the concomitant secretion of IL-17A and IFN-c from specific CD4(+) T cells in vitro. Therefore, the presence of IL-17A-positive T cells and the activation of Th17-related cytokines in acne lesions indicate that the Th17 pathway may play a pivotal role in the disease process, possibly offering new targets of therapy. 59 More recently, P. acnes was found to be highly sensitive to different concentrations of nitric oxide in nanoparticles (NOnp). NO-np significantly suppressed IL-1b, tumour necrosis factor-a (TNF-a), IL-8 and IL-6 from human monocytes, and IL-8 and IL-6 from human keratinocytes and peripheral blood mononuclear cells. These data suggest that NO-np can effectively prevent P. acnes-induced inflammation by both clearing the organism and inhibiting microbial stimulation of the innate immune response. 60 Several sebum free fatty acids (FFAs) such as linoleic and sapienic acid have antibacterial activity through stimulation of antimicrobial peptide (AMP) production against a broad range of Gram-positive bacteria such as P. acnes. 61 Different studies have demonstrated that AMPs are major contributors to cutaneous innate immunity. 62, 63 Among those, human b-defensin (hBD)-2 is upregulated in keratinocytes during inflammation and then accumulated in the skin. 64, 65 Because of their direct antimicrobial action, the secretion of these peptides provides defence against microbes such as P. acnes. 61 This has been confirmed by Choi et al. 66 through a study assessing the regional difference of inflammatory acne lesions, according to hBD-2 expression. Based on these elements, integrating AMPs in the armamentarium of current treatments targeting inflammation, such as topical retinoids, may be considered a future for acne management.
Propionibacterium acnes and the biofilm
Propionibacterium acnes is able to create a biofilm made of extracellular polysaccharides. This biological glue increases the adherence of P. acnes to follicular walls, favouring the modulation of integrins. Furthermore, it regulates the bacterial growth and metabolism, induces the development of P. acnes colonies and confers resistance to antimicrobial agents and to host inflammatory cells, resulting in a second mechanism of bacterial resistance. 67 The P. acnes biofilm is observed more frequently in patients with acne. 68 In these patients, the secretion of propionic acid by P. acnes led to the formation of keratinocytes with irregular cellular morphologies, confirming that P. acnes modulates the differentiation of keratinocytes, suggesting that it plays a role in the development of inflammatory acne lesions and in the formation of microcomedones. 69, 70 Consequently, the use of topical antibacterial compounds, such as benzoyl peroxide, or botanicals, which do not induce antibacterial resistance, may be a privileged alternative to limit the cutaneous P. acnes biofilm. 71 
Conclusions
In conclusion, the onset of acne involves different factors resulting in inflammation and the formation of different types of acne lesions. These factors include the quantitative and qualitative alteration of the sebum during puberty, called dysseborrhoea, triggered by internal factors such as hormonal or genetic factors, and external factors such as comedogenic cosmetics, aggressive detergents or drugs, which may stimulate mechanisms involved in the pathophysiologies of acne. The impact of stress and diet in the dysseborrhoea remains to be elucidated. Dysbiosis, the process leading to a disturbed skin barrier, and the disequilibrium of the cutaneous microbiome, resulting in the proliferation of P. acnes strains, are other important processes that trigger acne. P. acnes activates the innate immunity via the expression of PARs, TNF-a and TLRs, and the production of INF-c, IL-8, IL-12, TNF, IL-1 and MMPs by keratinocytes, resulting in the hyperkeratinization of the pilosebaceous unit.
(i) Rebalancing the natural microbiome of the skin by restoring the natural skin barrier in targeting cytokine receptors, (ii) limiting the proliferation of P. acnes on the skin using topical antibacterials which do not cause resistance and (iii) regulating the sebum outflow and composition will be the main acne treatment challenges in the future.
